Los Angeles Capital Management LLC Has $1.06 Million Stock Holdings in Centene Co. (NYSE:CNC)

Los Angeles Capital Management LLC boosted its position in shares of Centene Co. (NYSE:CNC) by 97.9% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 14,130 shares of the company’s stock after buying an additional 6,989 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Centene were worth $1,064,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of CNC. Crossmark Global Holdings Inc. lifted its holdings in Centene by 16.6% in the third quarter. Crossmark Global Holdings Inc. now owns 376,893 shares of the company’s stock valued at $28,372,000 after buying an additional 53,722 shares during the period. Sigma Planning Corp acquired a new position in shares of Centene in the 3rd quarter valued at $211,000. Oxbow Advisors LLC boosted its position in shares of Centene by 4.6% in the 3rd quarter. Oxbow Advisors LLC now owns 64,817 shares of the company’s stock worth $4,879,000 after purchasing an additional 2,875 shares during the last quarter. Lindbrook Capital LLC increased its holdings in Centene by 18.9% in the third quarter. Lindbrook Capital LLC now owns 4,496 shares of the company’s stock valued at $338,000 after purchasing an additional 714 shares during the last quarter. Finally, Assetmark Inc. lifted its stake in Centene by 193.1% in the third quarter. Assetmark Inc. now owns 3,640 shares of the company’s stock valued at $274,000 after buying an additional 2,398 shares during the period. Institutional investors own 93.63% of the company’s stock.

Centene Trading Up 1.1 %

Centene stock opened at $58.69 on Friday. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. The firm has a 50-day moving average of $68.61 and a 200-day moving average of $71.21. The company has a market cap of $29.63 billion, a price-to-earnings ratio of 10.08, a P/E/G ratio of 0.80 and a beta of 0.49. Centene Co. has a one year low of $57.56 and a one year high of $81.42.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. StockNews.com cut Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 28th. Barclays reduced their price target on shares of Centene from $97.00 to $91.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 29th. Jefferies Financial Group cut shares of Centene from a “buy” rating to a “hold” rating and lowered their price objective for the company from $83.00 to $69.00 in a research report on Wednesday, July 24th. Sanford C. Bernstein decreased their target price on Centene from $96.00 to $88.00 and set an “outperform” rating for the company in a research note on Wednesday, October 30th. Finally, Stephens reaffirmed an “equal weight” rating and set a $78.00 price target on shares of Centene in a research report on Monday, August 5th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $83.92.

Insider Activity at Centene

In other news, CFO Andrew Lynn Asher purchased 17,200 shares of the business’s stock in a transaction on Wednesday, November 13th. The stock was purchased at an average price of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the purchase, the chief financial officer now directly owns 486,847 shares in the company, valued at $28,305,284.58. The trade was a 3.66 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Sarah London acquired 4,117 shares of the stock in a transaction dated Friday, November 8th. The shares were purchased at an average price of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the purchase, the chief executive officer now directly owns 667,229 shares in the company, valued at $40,567,523.20. The trade was a 0.62 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.33% of the company’s stock.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.